Womens Imaging: Page 161

SBI: Don't overlook men when it comes to breast cancer
By Kate Madden Yee
The incidence of male breast cancer is rising, making it important to recognize risk factors and assess imaging use patterns to find the disease early, according to research presented April 5 at the Society for Breast Imaging (SBI) meeting in Hollywood, FL.
April 7, 2019
2016 10 05 17 45 45 493 Breast Cancer 400
SBI: AI improves DBT's performance in dense tissue
By Kate Madden Yee
Using artificial intelligence (AI) software with digital breast tomosynthesis (DBT) shortens reading time and improves breast cancer detection, sensitivity, and specificity in both dense and nondense breasts, according to research presented April 4 at the Society of Breast Imaging (SBI) annual meeting in Hollywood, FL.
April 4, 2019
2019 01 03 21 20 8068 Artificial Intelligence Ai 400
SBI: DBT users aren't implementing synthesized 2D
By Kate Madden Yee
Although synthesized 2D mammography has been cleared by the U.S. Food and Drug Administration to be used as a replacement for conventional 2D mammography when used with digital breast tomosynthesis (DBT), its adoption hasn't quite taken off, according to research presented April 4 at the Society of Breast Imaging (SBI) annual meeting in Hollywood, FL.
April 4, 2019
2016 08 26 11 32 34 470 Breast Mammo 400
Ikonopedia launches reporting software updates at SBI
By AuntMinnie.com staff writers
Breast imaging software developer Ikonopedia is highlighting updates to its reporting software at the Society for Breast Imaging (SBI) meeting in Hollywood, FL.
April 3, 2019
DBT screening mammography benefits women over 65
By Kate Madden Yee
Breast cancer screening with digital breast tomosynthesis (DBT) benefits women over 65, with fewer false positives and no statistically significant difference in sensitivity or cancer detection rate, according to a new study published online April 2 in Radiology.
April 2, 2019
2016 11 15 14 47 22 735 Breast Dbt 400
Synthesized 2D mammography works just as well as FFDM
By Kate Madden Yee
When used for breast screening, synthesized 2D mammography images generated by digital breast tomosynthesis (DBT) are just as useful as images from DBT plus traditional full-field digital mammography (FFDM), according to a study published online March 27 in the American Journal of Roentgenology.
March 31, 2019
2018 08 10 21 39 0206 Breast Cancer2 400
Week in Review: MRI of dementia | FDA mammography changes | New Board Review sections
By Brian Casey
March 29, 2019
Clinical rules reduce need for CTPA during pregnancy
By Abraham Kim
Using a set of clinical rules, researchers from the Netherlands and France helped nearly 40% of pregnant women suspected of having a pulmonary embolism avoid an unnecessary CT pulmonary angiography (CTPA) exam, according to a study published in the March 21 issue of the New England Journal of Medicine.
March 28, 2019
2016 09 02 11 37 18 762 Pregnant Woman 400
FDA proposes adding breast density reporting to MQSA
By Kate Madden Yee
The U.S. Food and Drug Administration (FDA) on March 27 proposed adding language on breast density to letters sent to women after their mammograms. The proposal would create a national standard for density reporting after years of state-by-state efforts.
March 26, 2019
2016 09 02 09 36 05 93 Fda Logo V2 400
Volpara expands GE distribution agreement globally
By AuntMinnie.com staff writers
Breast imaging software developer Volpara Solutions has expanded the distribution agreement it holds with GE Healthcare for its VolparaDensity software.
March 26, 2019
SIR: UFE bests myomectomy for fibroid treatment
By Kate Madden Yee
Uterine fibroid embolization (UFE) is a more effective treatment for fibroids than myomectomy, with fewer postprocedural complications. But many women aren't aware of UFE as a treatment option, according to research presented at the Society of Interventional Radiology (SIR) 2019 annual meeting in Austin, TX.
March 24, 2019
2017 08 25 13 47 26 468 Uterus Pelvic 400
CureMetrix wins FDA nod for mammo AI triage software
By AuntMinnie.com staff writers
Breast imaging computer-aided detection software developer CureMetrix has garnered U.S. Food and Drug Administration (FDA) clearance for cmTriage, an artificial intelligence (AI)-based software application designed to enable triaging of screening mammography exams.
March 21, 2019
Previous Page
Page 161 of 692
Next Page